Figure 2

![Figure 2: Comparison of advanced curcumin formulation strategies designed to improve bioavailability, including nanoparticles, liposomes, and phospholipid complexes. Enhanced delivery systems aim to overcome curcumin's poor oral absorption.]()

> Source: Stella Gagliardi et al. "Curcumin Formulations and Trials: What's New in Neurological Diseases.." *Molecules (Basel, Switzerland)*, 2020. PMID: [33217959](https://pubmed.ncbi.nlm.nih.gov/33217959/)

<figure>
  <img src="" alt="Comparison of advanced curcumin formulation strategies designed to improve bioavailability, including nanoparticles, liposomes, and phospholipid complexes. Enhanced delivery systems aim to overcome curcumin's poor oral absorption." />
  <figcaption>Figure 2. Comparison of advanced curcumin formulation strategies designed to improve bioavailability, including nanoparticles, liposomes, and phospholipid complexes. Enhanced delivery systems aim to overcome curcumin's poor oral absorption.<br>  Source: Stella Gagliardi et al. "Curcumin Formulations and Trials: What's New in Neurological Diseases.." <em>Molecules (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33217959/">33217959</a></figcaption>
</figure>